Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) is a gut peptide that, together with its receptor, GLP-1R, is expressed in the brain. Here we show that intracerebroventricular (i.c.v.) GLP-1 and [Ser(2)]exendin(1-9) (HSEGTFTSD; homologous to a conserved domain in the glucagon/GLP-1 family) enhance associative and spatial learning through GLP-1R. [Ser(2)]exendin(1-9), but not GLP-1, is also active when administered peripherally. GLP-1R-deficient mice have a phenotype characterized by a learning deficit that is restored after hippocampal Glp1r gene transfer. In addition, rats overexpressing GLP-1R in the hippocampus show improved learning and memory. GLP-1R-deficient mice also have enhanced seizure severity and neuronal injury after kainate administration, with an intermediate phenotype in heterozygotes and phenotypic correction after Glp1r gene transfer in hippocampal somatic cells. Systemic administration of [Ser(2)]exendin(1-9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons. Brain GLP-1R represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1 is involved in cognitive brain function and learning, 98”
From GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits (2026) · cites this paper as [98]
In the citing paper
“GLP1-RAs is known for its neuroprotective action, and more recent results have emerged, showing a potential benefit in people with AD [85,86,87].”
From Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies (2023) · cites this paper as [86]
In the citing paper
“They are involved in multiple biological pathways that could be beneficial in AD including improvement of BBB integrity and vascular health, promotion of homeostasis in microglia and astrocytes, positive effects on adaptative immune cells (including natural killer cells and activated regulatory T cells), improvement of synaptic viability, and neuroprotection [17–26].”
In the citing paper
“Preclinical results in murine models treated with GLP-1RAs suggest that the potential effects of semaglutide in AD may be exerted via impact on several AD-related pathophysiologic processes including neuroinflammatory pathways, vascular and BBB integrity, reduced synaptic loss, and neuroprotection [19, 21, 23–26, 46–48];”
Citations
Cites
Modification of seizure activity by electrical stimulation: II. Motor seizure
Racine, R. J. (1972) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(72)90177-0 · Cited by 7,171
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · cited 1×
“Immunohistochemical comparison of the CA3 subregion of the hippocampus using Fluorojade-B, a fluorochrome stain specific for degenerating neuron”
MethodKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationEnvironmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 732
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citation
Cited by
Items 401–500 of 859
Diabetes mellitus and Parkinson’s disease: dangerous liaisons between insulin and dopamine
Colosimo, C., Iuliis, A. D., Montinaro, E., Fatati, G., & Plebani, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320965 · Cited by 47
Khan, S., Sur, S., Newcomb, C. J., Appelt, E. A., & Stupp, S. I. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.01.036 · Cited by 43
The brain–adipose axis: A review of involvement of molecules
Shimizu, H., & Mori, M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500047245 · Cited by 44
Tam, J., Rosenberg, L. C., & Maysinger, D. (2004) · The FASEB Journal · doi:10.1096/fj.04-1894fje · Cited by 45
DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship
Alrouji, M., Al-Kuraishy, H. M., Albuhadily, A. K., Al-Gareeb, A. I., Elekhnawy, E., & Batiha, G. E. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00500-5 · Cited by 41
Pleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 46
Park, S., Hong, S. M., & Sung, S. R. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.12.018 · Cited by 46
Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral Endopeptidase
Walther, T., Albrecht, D., Becker, M., Schubert, M., Kouznetsova, E., Wiesner, B., Maul, B., Schliebs, R., Grecksch, G., Furkert, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004590 · Cited by 40
Pancreatic β-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs
D’Amico, E., Hui, H., Khoury, N., Mario, U. D., & Perfetti, R. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01655 · Cited by 46
Li, H., Lee, C. H., Yoo, K.-Y., Choi, J. H., Park, O. K., Yan, B. C., Byun, K., Lee, B., Hwang, I. K., & Won, M.-H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.040 · Cited by 39
Urkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 45
Intranasal Glucagon: A Promising Approach for Treatment of Severe Hypoglycemia
Pontiroli, A. E. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814557518 · Cited by 39
Takamoto, I., Terauchi, Y., Kubota, N., Ohsugi, M., Ueki, K., & Kadowaki, T. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00951.x · Cited by 46
A novel role of circadian transcription factor DBP in hippocampal plasticity
Klugmann, M., Leichtlein, C. B., Symes, C. W., Klaussner, B. K., Brooks, A. I., Young, D., & During, M. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.09.019 · Cited by 39
Self-citationPadovani, A., Galli, A., Bazzoli, E., Tolassi, C., Caratozzolo, S., Gumina, B., Benussi, A., Libri, I., Outeiro, T. F., & Pilotto, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14556 · Cited by 40
Tramutola, A., Arena, A., Cini, C., Butterfield, D. A., & Barone, E. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1246183 · Cited by 38
Kaminari, A., Tsilibary, E. C., & Tzinia, A. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180035 · Cited by 42
Gesù, C. M. D., Matz, L. M., & Buffington, S. A. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.05.003 · Cited by 53
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
Bak, A. M., Egefjord, L., Gejl, M., Steffensen, C., Stecher, C. W., Smidt, K., Brock, B., & Rungby, J. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.600691 · Cited by 36
Jia, Y., Gong, N., Li, T., Zhu, B., & Wang, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.008 · Cited by 38
Jia, X.-T., Ye-Tian, Yuanli, Zhang, G., Liu, Z., Di, Z., Ying, X., Yan, F., Song, E., Qi, J., et al. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.03.016 · Cited by 38
Li, Y., Fang, L., Zheng, T., Shi, L., Zhang, Z., Niu, T., Wang, Q., Zhao, D., Li, W., & Zhao, P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112299 · Cited by 36
Intranasal Delivery of Human β-Amyloid Peptide in Rats: Effective Brain Targeting
Sipos, E., Kurunczi, A., Fehér, A., Penke, Z., Fülöp, L., Kasza, Á., Horváth, J., Horvát, S., Veszelka, S., Balogh, G. E., et al. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9463-6 · Cited by 43
The gut microbiota modulate locomotion via vagus-dependent glucagon-like peptide-1 signaling
Lai, T.-T., Tsai, Y.-H., Liou, C.-W., Fan, C., Hou, Y.-T., Yao, T.-H., Chuang, H.-L., & Wu, W. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00477-w · Cited by 40
Lv, R., Zhao, Y., Wang, X., He, Y., Dong, N., Min, X., Liu, X., Yu, Q., Yuan, K., Yue, H., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113222 · Cited by 54
Incretin Therapies: Effects Beyond Glycemic Control
Mudaliar, S. R. D., & Henry, R. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.014 · Cited by 37
The CNS as a target for peptides and peptide-based drugs
Banks, W. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.6.707 · Cited by 35
Self-citationCracking the combination: Gut hormones for the treatment of obesity and diabetes
Alexiadou, K., Anyiam, O., & Tan, T. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12664 · Cited by 34
Genetic disruption of the Gipr in Apoe−/− mice promotes atherosclerosis
Pujadas, G., Baggio, L. L., Kaur, K. D., McLean, B. A., Cao, X., & Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101586 · Cited by 34
Self-citationEbdrup, B. H., Knop, F. K., Ishøy, P. L., Rostrup, E., Fagerlund, B., Lublin, H., & Glenthøj, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-92 · Cited by 34
“Besides the effects of GLP-1 analogs on hyperglycemia and obesity (and possibly on hepatic lipid deposition), activation of central GLP-1 receptors may stimulate neural plasticity and prevent apoptosis, thereby suggesting involvement of GLP-1 in neuroprotection and learning [41,42].”
BackgroundLi, H., Jia, Z., Li, G., Zhao, X.-Z., Sun, P., Wang, J., Fan, Z., & Lv, G. (2015) · PubMed · Cited by 40
Han, W., Li, Y., Cheng, J., Zhang, J., Chen, D., Fang, M., Xiang, G., Wu, Y., Zhang, H., Xu, K., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15501 · Cited by 36
Shandilya, A., & Mehan, S. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05328-6 · Cited by 37
Mossello, E., Ballini, E., Boncinelli, M., Monami, M., Lonetto, G., Mello, A. M., Tarantini, F., Baldasseroni, S., Mannucci, E., & Marchionni, N. (2011) · Experimental Diabetes Research · doi:10.1155/2011/281674 · Cited by 37
Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis
Vegas‐Suárez, S., Simón, J., Martínez‐Chantar, M. L., & Moratalla, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.864263 · Cited by 40
Tran, J., Parekh, S., Rockcole, J., Wilson, D., & Parmar, M. S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123001 · Cited by 38
Koychev, I. G., Reid, G., Nguyen, M., Mentz, R. J., Joyce, D. W., Shah, S. H., & Holman, R. R. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01573-x · Cited by 39
Tackling dipeptidyl peptidase IV in neurological disorders
Castorina, A., Al‐Badri, G., Leggio, G. M., Musumeci, G., Marzagalli, R., & Drago, F. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.224365 · Cited by 39
Anand, U., Yiangou, Y., Akbar, A., Quick, T., MacQuillan, A. H. F., Fox, M., Sinisi, M., Korchev, Y. E., Jones, B. J., Bloom, S. R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198024 · Cited by 35
Zhang, Y., Liu, Y.-L., Xu, J., Sun, Q., Yu, F., Cheng, J., Peng, B., Liu, W., Xiao, Z., Yin, J., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.004 · Cited by 36
Citraro, R., Iannone, M., Leo, A., Caro, C. D., Nesci, V., Tallarico, M., Abdalla, K., Palma, E., Arturi, F., Sarro, G. D., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.001 · Cited by 34
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Jones, B. D. M., Farooqui, S., Kloiber, S. M., Husain, M. O., Mulsant, B. H., & Husain, M. I. (2021) · Life · doi:10.3390/life11080819 · Cited by 43
Le, T. D., Nguyen, N. P. T., Tran, T. T. H., Cong, T. L., Nguyen, L. H. T., Nhu, B. D., Nguyen, S. T., Ngo, M. V., Dinh, T. H., Nguyen, H. T., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s344532 · Cited by 41
Effects of Glucagon-like peptide 1 (GLP-1) analogs in the hippocampus
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., & Mallo, F. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2021.12.005 · Cited by 35
Jonik, S., Marchel, M., Grabowski, M., Opolski, G., & Mazurek, T. (2022) · Biology · doi:10.3390/biology11020288 · Cited by 33
Voss, U., Sand, E., Hellström, P. M., & Ekblad, E. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-30 · Cited by 36
Rahman, M. H., Jha, M. K., & Suk, K. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151204001234 · Cited by 39
Farokhnia, M., Fede, S. J., Grodin, E. N., Browning, B. D., Crozier, M. E., Schwandt, M. L., Hodgkinson, C. A., Momenan, R., & Leggio, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-17190-3 · Cited by 32
Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases
Plascencia‐Villa, G., & Perry, G. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512486 · Cited by 34
Süyen, G. G., Işbil-Büyükcoşkun, N., & Kahveci, N. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.02.002 · Cited by 34
Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
Fujita, S., Ushio, S., Ozawa, N., Masuguchi, K., Kawashiri, T., Oishi, R., & Egashira, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141921 · Cited by 34
Abbas, N. A. T., & Kabil, S. L. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1414-z · Cited by 32
Packer, M. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1185 · Cited by 35
Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches
Suresh, J., Khor, I. W., Kaur, P., Heng, H. L., Torta, F. T., Dawe, G. S., Tai, E. S., & Tolwinski, N. S. (2020) · FEBS Journal · doi:10.1111/febs.15540 · Cited by 36
Piątkowska‐Chmiel, I., Gawrońska‐Grzywacz, M., Popiołek, Ł. P., Herbet, M., & Dudka, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-10187-y · Cited by 36
Shan, Z., Peng, M., Fan, H., Lü, Q., Lü, P., Zhao, C., & Chen, Y. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.086 · Cited by 35
Zhang, R., Zhang, H., Xu, L., Ma, K., Wallrapp, C., & Jonas, J. B. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02044.x · Cited by 32
Diabetes and Stem Cell Function
Fujimaki, S., Wakabayashi, T., Takemasa, T., Asashima, M., & Kuwabara, T. (2015) · BioMed Research International · doi:10.1155/2015/592915 · Cited by 38
Berberine chloride improved synaptic plasticity in STZ induced diabetic rats
Moghaddam, H. K., Baluchnejadmojarad, T., Roghani, M., Goshadrou, F., & Ronaghi, A. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9411-5 · Cited by 31
Wang, X., Wang, L., Xu, Y., Yu, Q., Li, L., & Guo, Y. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0548-z · Cited by 31
Park, S. W., Mansur, R. B., Lee, Y. L., Lee, J.-H., Seo, M. K., Choi, A. J., McIntyre, R. S., & Lee, J. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00756 · Cited by 36
Park, C. R., Moon, M. J., Park, S., Kim, D., Cho, E. B., Millar, R. P., Hwang, J., & Seong, J. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065420 · Cited by 32
Kumar, K. G., Poole, A. C., York, B., Vólaufová, J., Zuberi, A. R., & Richards, B. K. S. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00491.2006 · Cited by 32
Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat
Yang, H., Li, H., Wang, Z., Shi, Y., Jiang, G., & Zeng, F. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.06.042 · Cited by 34
Liu, S., Jin, Z., Zhang, Y., Rong, S., He, W., Sun, K., Wan, D., Huo, J., Xiao, L., Li, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00136 · Cited by 36
Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality
Lezoualc’h, F., Badimón, L., Baker, H. E., Bernard, M., Czibik, G., de Boer, R. A., d’Humières, T., Kergoat, M., Kowala, M. C., Rieusset, J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac152 · Cited by 33
GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
Złotek, M., Kurowska, A., Herbet, M., & Piątkowska‐Chmiel, I. (2023) · Biomedicines · doi:10.3390/biomedicines11113035 · Cited by 32
Sun, H. J., Knippenberg, S., Thau, N., Ragancokova, D., Körner, S., Huang, D., Dengler, R., Döhler, K. D., & Petri, S. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9900-9 · Cited by 30
Dong, W., Miao, Y., Chen, A., Cheng, M., Ye, X., Song, F., & Zheng, G. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.045 · Cited by 29
Wang, Z.-J., Han, W.-N., Chai, S.-F., Li, Y., Fu, C.-J., Wang, C.-F., Cai, H.-Y., Li, X., Wang, X., Hölscher, C., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.022 · Cited by 35
Li, Y., Li, L., & Hölscher, C. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0018 · Cited by 31
Gastrointestinal hormones in regulation of memory
Mandal, A., Prabhavalkar, K. S., & Bhatt, L. K. (2018) · Peptides · doi:10.1016/j.peptides.2018.02.003 · Cited by 35
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
Pearson, S. M., Kietsiriroje, N., & Ajjan, R. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s229802 · Cited by 38
Zhang, J., Yi, T., Cheng, S., & Zhang, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106715 · Cited by 29
Perez, F. A., Elfers, C., Yanovski, J. A., Shoemaker, A. H., Abuzzahab, M. J., & Roth, C. L. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14366 · Cited by 29
“GLP-1 receptors are expressed in hippocampal neurons(38) and GLP-1 has neuroprotective effects and modifies synaptic plasticity.(39) One possibility for increased sensitivity to GLP1RA therapy in HO patients with MB damage could be altered regulation and increased sensitivity of hippocampal GLP-1 pathways as a result…”
BackgroundGil-Lozano, M., Romaní-Pérez, M., Outeiriño-Iglesias, V., Vigo, E., Brubaker, P. L., González-Matías, L. C., & Mallo, F. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00529.2012 · Cited by 29
Qi, L., Chen, Z., Wang, Y., Liu, X., Liu, X., Ke, L., Zheng, Z., Lin, X., Zhou, Y., Liu, L., et al. (2017) · Europe PMC (PubMed Central) · Cited by 37
Yang, J., Lin, Y.-T., Chen, W., Yang, Y., Sun, S., & Chen, S. (2020) · Biology · doi:10.3390/biology9110348 · Cited by 32
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
Poudyal, H. (2015) · Acta Physiologica · doi:10.1111/apha.12604 · Cited by 34
Wang, X., Yang, W., Hölscher, C., Wang, Z., Cai, H., Li, Q., & Qi, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23181 · Cited by 32
Dai, F. F., Bhattacharjee, A., Liu, Y., Batchuluun, B., Zhang, M., Wang, X. S., Huang, X., Luu, L., Zhu, D. Y., Gaisano, H. Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.648592 · Cited by 29
Koshal, P., & Kumar, P. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1890-4 · Cited by 33
Fasting enhances extinction retention and prevents the return of fear in humans
Shi, L., Deng, J., Chen, S., Que, J., Sun, Y., Wang, Z., Guo, X., Han, Y., Zhou, Y., Zhang, X., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0260-1 · Cited by 30
Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors
Ferraris, D. V., Ko, Y.-S., Calvin, D. C., Chiou, T., Lautar, S. L., Thomas, B. E., Wozniak, K. M., Rojas, C. J., Kalish, V. J., & Belyakov, S. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.057 · Cited by 28
Tests for learning and memory in rodent regulatory studies
Vorhees, C. V., & Williams, M. T. (2024) · Current Research in Toxicology · doi:10.1016/j.crtox.2024.100151 · Cited by 36
Gejl, M., Rungby, J., Brock, B., & Gjedde, A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12240 · Cited by 27
Riley, D. E., & Krieger, J. N. (2008) · Gene · doi:10.1016/j.gene.2008.09.025 · Cited by 28
Peptides and aging: Their role in anorexia and memory
Morley, J. E. (2015) · Peptides · doi:10.1016/j.peptides.2015.04.007 · Cited by 29
Sartorius, T., Drescher, A., Panse, M., Laštovička, P., Peter, A., Weigert, C., Kostenis, E., Ullrich, S., & Häring, H.-U. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374031 · Cited by 27
Intestinal Incretins and the Regulation of Bone Physiology
Ramsey, W. A., & Isales, C. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-66653-2_2 · Cited by 29
Wang, M., Yoon, G., Song, J., & Jo, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-87809-4 · Cited by 28
Krass, M., Volke, A., Rünkorg, K., Wegener, G., Lund, S., Abildgaard, A., Vasar, E., & Volke, V. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.36 · Cited by 27
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
Johnstone, S., & Albert, J. S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.084 · Cited by 28
Glucagon-like peptide-1: physiology and therapeutic potential
Holst, J. J. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000151395.52819.47 · Cited by 30
GLP-1-Based Strategies: A Physiological Analysis of Differential Mode of Action
Burcelin, R., Gourdy, P., & Dalle, S. (2014) · Physiology · doi:10.1152/physiol.00009.2013 · Cited by 26
“This conclusion is also supported by recent data from the literature, since the central role of GLP-1 has now gained a wide range of effects, including neuroprotection from neurotoxins and cognitive functions such as learning (38).”
BackgroundResultCao, Y., Yu, F., Lyu, Y., & Lu, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1034243 · Cited by 26
Mansur, R. B., Fries, G. R., Trevizol, A. P., Subramaniapillai, M., Lovshin, J. A., Lin, K., Vinberg, M., Ho, R., Brietzke, E. M., & McIntyre, R. S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.10.007 · Cited by 29
Iwasa, K., Yamamoto, S., Yamashina, K., Sakemoto, C., Yagishita-Kyo, N., Maruyama, K., Awaji, T., Takei, Y., Hirasawa, A., & Yoshikawa, K. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02361-2 · Cited by 27
Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders
Vadnie, C. A., Park, J. H., Gawad, N. A., Ho, A. M., Hinton, D. J., & Choi, D. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00288 · Cited by 27
DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review
Chalichem, N. S. S., Gonugunta, C., Krishnamurthy, P. T., & Basavan, D. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517722005 · Cited by 28
Metadata
- Authors
- During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., & Haile, C. N.
- Affiliations
- University of Auckland (NZ)
- Thomas Jefferson University (US)
- St. Louis VA Medical Center (US)
- University of Toronto (CA)
- Corresponding author
- During, Matthew J
- ORCID
- Venue
- Nature Medicine
- Published
- 2003-08-17
- Volume
- 9
- Issue
- 9
- Pages
- 1173-1179
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2124852816
- Cited by
- 851
- References
- 42
- Citations by year
- 2026: 34 · 2025: 40 · 2024: 50 · 2023: 39 · 2022: 58 · 2021: 53 · 2020: 44 · 2019: 36 · 2018: 37 · 2017: 39 · 2016: 34 · 2015: 54 · 2014: 46 · 2013: 47 · 2012: 43
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Marsden Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- GLP-1 receptor, glucagon-like peptide-1, associative learning, spatial learning, memory, hippocampus, neuroprotection, kainate-induced seizures, neuronal apoptosis, cognitive enhancement, gut-brain signaling
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Administration, Intranasal, Amino Acid Sequence, Animals, Behavior, Animal, Cognition, Glucagon, Hippocampus, Kainic Acid, Learning, Male, Molecular Sequence Data, Neurons, Peptide Fragments, Protein Precursors, Seizures, Signal Transduction, Gene Expression, Rats, Sprague-Dawley, Apoptosis, Sequence Homology, Amino Acid, Gene Transfer Techniques, Receptors, Glucagon, Mice, Knockout, Neuroprotective Agents, Mice, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.